Innovation Pharmaceuticals Inc (IPIX)

[RJFL]

What a rough day. As others have mentioned I think this was the wrong trial design for B. Was at a conference this past weekend and heard Dr Peter McCullough speak and a tidbit sticks out. There was talk about Remdesevir and how it's use in late stage covid illness was illogical because the replication phase for the virus was already past when it's typically given in a hospital, advanced illness case (replication phase is 8 days or so). Can't help but wonder if B is given earlier, during the replication phase, would there be a benefit? Regardless we need to focus in areas previously shown to have great promise. This was a hail mary usage with a dog of a drug (remdesevir) in moderate/severe covid patients (e.g. advanced stages of the covid). Very saddened at the results but not shocked.